Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.120
0.00 (0.00%)
Feb 17, 2026, 4:00 PM EST - Market closed
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $98.87 million as of February 17, 2026. Its market cap has increased by 209.72% in one year.
Market Cap
98.87M
Enterprise Value
62.56M
1-Year Change
209.72%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $98.87M, a decrease of -61.45%. That is a compound annual growth rate of -19.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 98.87M | -17.04% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 105.19M |
| Turn Therapeutics | 103.35M |
| Dogwood Therapeutics | 102.22M |
| Cassava Sciences | 100.96M |
| Actuate Therapeutics | 100.64M |
| Agenus | 99.30M |
| Artiva Biotherapeutics | 98.18M |
| Equillium | 95.60M |